Revvity, Inc.
RVTYNYSEHealthcare● Active
$100.30
+$1.93(+1.96%)
Market Cap$11.2B
P/E Ratio—
52W High$118.3
52W Low$81.22
Revvity, Inc.（RVTY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RVTY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B |
| Cost of Revenue | $1.34B | $1.43B | $1.43B | $1.55B | $1.55B |
| Gross Profit | $1.52B | $1.32B | $1.32B | $1.76B | $2.28B |
| Gross Margin %(computed) | 53.08% | 48.01% | 48.07% | 53.16% | 59.62% |
| Operating Expenses | |||||
| R&D Expenses | $0.22B | $0.20B | $0.22B | $0.22B | $0.20B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $1.16B | $0.91B | $0.92B | $0.98B | $0.94B |
| Operating Income | $0.36B | $0.41B | $0.40B | $0.78B | $1.34B |
| Operating Margin %(computed) | 12.49% | 14.90% | 14.52% | 23.59% | 35.01% |
| Interest Income | $0.03B | $0.07B | $0.07B | $0.00B | $0.00B |
| Interest Expense | $0.09B | $0.10B | $0.10B | $0.10B | $0.10B |
| Income Before Tax | $0.27B | $0.32B | $0.18B | $0.65B | $1.20B |
| Income Tax Expense | $0.03B | $0.03B | $0.00B | $0.14B | $0.31B |
| Net Income | $0.24B | $0.30B | ($0.12B) | $0.57B | $0.94B |
| Net Margin %(computed) | 8.46% | 10.74% | -4.30% | 17.19% | 24.64% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.08 | $2.41 | $-0.95 | $4.51 | $8.12 |
| Wtd Avg Shares | 0.11B | 0.12B | 0.12B | 0.13B | 0.12B |
| EBITDA | $0.66B | $0.84B | $0.71B | $1.18B | $1.62B |
| EBITDA Margin %(computed) | 23.20% | 30.50% | 25.94% | 35.71% | 42.25% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Revvity, Inc.
关于Revvity, Inc.（RVTY）损益表
Revvity, Inc.（RVTY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，RVTY实现营收$2.86B，毛利润$1.52B（毛利率53.08%），净利润$0.24B（净利率8.46%）。
常见问题
RVTY · 4 问Revvity, Inc.（RVTY）2025财年营收为$2.86B，同比up3.7%。
RVTY revenueRVTY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08